Expression of the SH2D1A gene is regulated by a combination of transcriptional and post‐transcriptional mechanisms
Open Access
- 11 October 2004
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 34 (11) , 3176-3186
- https://doi.org/10.1002/eji.200324755
Abstract
The SH2D1A gene, which is altered or deleted in patients with X-linked lymphoproliferative disease, encodes the small protein SAP (for SLAM-associated protein) that is expressed in T and NK cells. A 22-bp fragment in close proximity to an initiator-like site was defined as the basal promoter of mouse SH2D1A, and a highly homologous 33-bp segment was defined as the human basal promoter. When an Ets consensus site was mutated, no reporter activity was detectable. Gel mobility supershift assays revealed that the two transcription factors Ets-1 and Ets-2 bind to the human and mouse sequences. The involvement of Ets-1 and Ets-2 in expression of SH2D1A was functionally confirmed by overexpression studies of their dominant-negative forms. We also found that SH2D1A mRNA decays very rapidly in mouse T cells, and its 3′ untranslated region (UTR) has RNA-destabilizing activity in transfection studies with reporter/3′ UTR constructs. As judged by RNA-gel mobility shift assays, this rapid degradation of SH2D1A mRNA was due to a balance in binding of the factors AUF1 and HuR to its 3′ UTR. Although the SH2D1A mRNA level decreased upon triggering of the T cell receptor (TCR), the RNA degradation rate itself was not altered by TCR engagement.Keywords
This publication has 35 references indexed in Scilit:
- T Cell-specific Expression of the MurineCD3δ PromoterJournal of Biological Chemistry, 2002
- Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 familyImmunogenetics, 2002
- Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAPBlood, 2001
- X-Linked Lymphoproliferative Disease: A Progressive ImmunodeficiencyAnnual Review of Immunology, 2001
- HuR and mRNA stabilityCellular and Molecular Life Sciences, 2001
- Signal transduction and the Ets family of transcription factorsOncogene, 2000
- X-Linked Lymphoproliferative DiseaseThe Journal of Experimental Medicine, 2000
- TFII Is Required for Transcription of the Naturally TATA-less but Initiator-containing Vβ PromoterJournal of Biological Chemistry, 1996
- Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogeneNature, 1995
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991